Pacira BioSciences, Inc.
PCRX· Nasdaq
Released May 4, 2017, during market hours
10-Q filed May 4, 2017, 34 days after period end · 0001396814-17-000015
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $68.43M | $65.47M | $58.32M | $36.66M |
| Net Income | -$19.87M | -$3.85M | $1.26M | -$11.48M |
| EPS Diluted | -$0.52 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| -$0.10 |
| $0.03 |
| -$0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.